These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 12110435)
1. Heparan sulfate abnormalities in exostosis growth plates. Hecht JT; Hall CR; Snuggs M; Hayes E; Haynes R; Cole WG Bone; 2002 Jul; 31(1):199-204. PubMed ID: 12110435 [TBL] [Abstract][Full Text] [Related]
2. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes. Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543 [TBL] [Abstract][Full Text] [Related]
3. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Stickens D; Zak BM; Rougier N; Esko JD; Werb Z Development; 2005 Nov; 132(22):5055-68. PubMed ID: 16236767 [TBL] [Abstract][Full Text] [Related]
4. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis. Hall CR; Cole WG; Haynes R; Hecht JT Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711 [TBL] [Abstract][Full Text] [Related]
5. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones. Zak BM; Schuksz M; Koyama E; Mundy C; Wells DE; Yamaguchi Y; Pacifici M; Esko JD Bone; 2011 May; 48(5):979-87. PubMed ID: 21310272 [TBL] [Abstract][Full Text] [Related]
6. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses. Pacifici M Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722 [TBL] [Abstract][Full Text] [Related]
7. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes. Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766 [TBL] [Abstract][Full Text] [Related]
8. Epiphyseal abnormalities, trabecular bone loss and articular chondrocyte hypertrophy develop in the long bones of postnatal Ext1-deficient mice. Sgariglia F; Candela ME; Huegel J; Jacenko O; Koyama E; Yamaguchi Y; Pacifici M; Enomoto-Iwamoto M Bone; 2013 Nov; 57(1):220-31. PubMed ID: 23958822 [TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses. Huegel J; Sgariglia F; Enomoto-Iwamoto M; Koyama E; Dormans JP; Pacifici M Dev Dyn; 2013 Sep; 242(9):1021-32. PubMed ID: 23821404 [TBL] [Abstract][Full Text] [Related]
10. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses. Trebicz-Geffen M; Robinson D; Evron Z; Glaser T; Fridkin M; Kollander Y; Vlodavsky I; Ilan N; Law KF; Cheah KS; Chan D; Werner H; Nevo Z Int J Exp Pathol; 2008 Oct; 89(5):321-31. PubMed ID: 18452536 [TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations. Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558 [TBL] [Abstract][Full Text] [Related]
12. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity. Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482 [TBL] [Abstract][Full Text] [Related]
13. EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses. Legeai-Mallet L; Rossi A; Benoist-Lasselin C; Piazza R; Mallet JF; Delezoide AL; Munnich A; Bonaventure J; Zylberberg L J Bone Miner Res; 2000 Aug; 15(8):1489-500. PubMed ID: 10934647 [TBL] [Abstract][Full Text] [Related]
14. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672 [TBL] [Abstract][Full Text] [Related]
15. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses. Chen WC; Chi CH; Chuang CC; Jou IM J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657 [TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of EXT1 and Heparan Sulphate Deficiency Associated with Hereditary Multiple Exostoses in a Pakistani Family. Ajmal M; Muhammad H; Nasir M; Shoaib M; Malik SA; Ullah I Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676722 [No Abstract] [Full Text] [Related]
18. Biosynthesis of heparan sulfate in EXT1-deficient cells. Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530 [TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of the EXT2 gene in developing chondrocytes enhances the synthesis of heparan sulfate and bone formation in mice. Morimoto K; Shimizu T; Furukawa K; Morio H; Kurosawa H; Shirasawa T Biochem Biophys Res Commun; 2002 Apr; 292(4):999-1009. PubMed ID: 11944914 [TBL] [Abstract][Full Text] [Related]
20. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses. Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]